KEY FEATURES
| Full Name | Gamma-Glutamyltransferase 1 |
|---|---|
| Synonym | CD224; G-GT1; GTG; Gamma-glutamyltranspeptidase 1; Glutathione hydrolase 1; Leukotriene-C4 hydrolase; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 1.56-100ng/mL |
| Sensitivity | 0.59ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human gGT1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human gGT1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human gGT1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human gGT1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human gGT1. You can calculate the concentration of Human gGT1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human gGT1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 5.07 | 12.49 | 34.5 | 5.49 | 13.29 | 37.35 |
| Standard deviation | 0.33 | 0.7 | 1.29 | 0.36 | 0.58 | 1.37 |
| CV(%) | 6.47 | 5.62 | 3.74 | 6.52 | 4.4 | 3.66 |
RECOVERY
The recovery of Human gGT1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 91-108 | 99 |
| EDTA plasma (n=8) | 94-109 | 100 |
| Cell culture media (n=8) | 83-95 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human gGT1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with GLb ELISA Kits
| Hexb rtu ELISA Kit | publications with GLb and Hexb |
| Gla rtu ELISA Kit | publications with GLb and Gla |
| Hexa rtu ELISA Kit | publications with GLb and Hexa |
| Galns rtu ELISA Kit | publications with GLb and Galns |
| Gusb rtu ELISA Kit | publications with GLb and Gusb |
| Gba rtu ELISA Kit | publications with GLb and Gba |
Pathways associated with GLb ELISA Kit
| Asparagine N-linked Glycosylation Pathway | Asparagine N-linked Glycosylation Pathway |
| Biosynthesis Of The N-glycan Precursor (dolichol Lipid-linked Oligosaccharide, LLO) And Transfer To A Nascent Protein Pathway | Biosynthesis Of The N-glycan Precursor (dolichol Lipid-linked Oligosaccharide, LLO) And Transfer To A Nascent Protein Pathway |
| Galactose Metabolism Pathway | Galactose Metabolism Pathway |
| Glycosaminoglycan Degradation Pathway | Glycosaminoglycan Degradation Pathway |
| Glycosaminoglycan Metabolism Pathway | Glycosaminoglycan Metabolism Pathway |
| Glycosphingolipid Biosynthesis - Ganglio Series Pathway | Glycosphingolipid Biosynthesis - Ganglio Series Pathway |
| Glycosphingolipid Metabolism Pathway | Glycosphingolipid Metabolism Pathway |
Diseases associated with GLb ELISA Kit
| Gangliosidosis, GM1 | publications with GLb and Gangliosidosis, GM1 |
| Nervous System Diseases | publications with GLb and Nervous System Diseases |
| Mucopolysaccharidosis IV | publications with GLb and Mucopolysaccharidosis IV |
| Disease Models, Animal | publications with GLb and Disease Models, Animal |
| Inflammation | publications with GLb and Inflammation |
| Adenocarcinoma | publications with GLb and Adenocarcinoma |
| Kidney Diseases | publications with GLb and Kidney Diseases |
| Carcinoma, Hepatocellular | publications with GLb and Carcinoma, Hepatocellular |
| Weight Loss | publications with GLb and Weight Loss |
| Necrosis | publications with GLb and Necrosis |
Organs/Tissues associated with GLb ELISA Kit
| Blood | publications with GLb and Blood |
| Brain | publications with GLb and Brain |
| Skin | publications with GLb and Skin |
| Eye | publications with GLb and Eye |
| Liver | publications with GLb and Liver |
| Kidney | publications with GLb and Kidney |
| Joint | publications with GLb and Joint |
| Connective Tissue | publications with GLb and Connective Tissue |
| Bone | publications with GLb and Bone |
| Lung | publications with GLb and Lung |